Increasing population is suffering from neurodegenerative and heart diseases. Close to 90% of all new drugs fail in clinical trials driven by that animal testing may not be conclusive in human applications. This costs USD billions and several patient years for a new drug to be developed.
APPERCELL’s goal is to revolutionise biomedical research and drug development by commercialising a high-throughput microelectrode array system with automated data analysis platform, which enables faster, safer, and more efficient drug discovery while minimising the need for live animal experiments.
The company’s mission is to make people lives better. They also wish to set a role model for the regional bio/medtech community and grow with the local talent.